Works about TAZOBACTAM

Results: 522

Antimicrobials: Triple therapy for MRSA.

Published in:

Nature Reviews Microbiology, 2015, v. 13, n. 11, p. 661, doi. 10.1038/nrmicro3579

By:

Waldron, Denise

Publication type:

Article

Serum β-lactam concentrations in critically ill patients with cirrhosis: a matched case-control study.

Published in:

Liver International, 2016, v. 36, n. 7, p. 1002, doi. 10.1111/liv.13039

By:

Lheureux, Olivier;
Trepo, Eric;
Hites, Maya;
Cotton, Frederic;
Wolff, Fleur;
Surin, Rudy;
Creteur, Jacques;
Vincent, Jean ‐ Louis;
Gustot, Thierry;
Jacobs, Frederique;
Taccone, Fabio S.

Publication type:

Article

A Fatal Side Effect of Piperacillin/Tazobactam Use: A Case Report.

Published in:

Eurasian Journal of Critical Care, 2021, v. 3, n. 3, p. 120

By:

Duyan, Murat;
Günlü, Serhat;
Sarıdaş, Ali;
Cander, Basar;
Solaç, Yıldızhan

Publication type:

Article

Design of a novel colorimetric method based on AuNPs for tazobactam and piperacillin detection.

Published in:

Journal of Research in Pharmacy, 2023, v. 27, n. 3, p. 1066, doi. 10.29228/jrp.399

By:

ERDOGAN, Zehra Ozden;
BALCI, Hakan

Publication type:

Article

Efficacy of topical application of antibiotic (piperacillin + tazobactum) in preventing sternal wound infections post sternotomy for cardiac procedures.

Published in:

Indian Journal of Basic & Applied Medical Research, 2023, v. 12, n. 3, p. 210, doi. 10.36855/IJBAMR/2022/98215.5925

By:

S., RAMA ALAGAPPAN;
LAL, SAMEER;
KUMAR, SATISH;
GEELANI, MUHAMMAD ABID;
SATYARTHI, SUBODH

Publication type:

Article

Molecular Adsorbent Recirculating System ( MARS<sup>®</sup>) removal of piperacillin/tazobactam in a patient with acetaminophen-induced acute liver failure.

Published in:

Transplant Infectious Disease, 2013, v. 15, n. 2, p. 214, doi. 10.1111/tid.12031

By:

Ruggero, M.A.;
Argento, A.C.;
Heavner, M.S.;
Topal, J.E.

Publication type:

Article

Infection with Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in solid organ transplantation.

Published in:

Transplant Infectious Disease, 2012, v. 14, n. 2, p. 198, doi. 10.1111/j.1399-3062.2011.00688.x

By:

Bergamasco, M.D.;
Barroso Barbosa, M.;
Oliveira Garcia, D.;
Cipullo, R.;
Moreira, J.C.M.;
Baia, C.;
Barbosa, V.;
Abboud, C.S.

Publication type:

Article

Safety, Tolerability, and Pharmacokinetics of 3 g of Ceftolozane/Tazobactam in Healthy Adults: A Randomized, Placebo‐Controlled, Multiple‐Dose Study.

Published in:

Clinical Pharmacology in Drug Development, 2018, v. 7, n. 4, p. 382, doi. 10.1002/cpdd.429

By:

Yu, Brian;
Adedoyin, Adedayo;
Hershberger, Ellie;
Caro, Luzelena;
Xiao, Alan;
Rhee, Elizabeth G.;
Huntington, Jennifer A.

Publication type:

Article

Antimicrobial prophylaxis for transrectal prostatic biopsy: a prospective study of ciprofloxacin vs piperacillin/tazobactam.

Published in:

BJU International, 2002, v. 90, n. 7, p. 700, doi. 10.1046/j.1464-410X.2002.02991.x

By:

Cormio, L.;
Berardi, B.;
Callea, A.;
Fiorentino, N.;
Sblendorio, D.;
Zizzi, V.;
Traficante, A.

Publication type:

Article

Piperacillin-Tazobactam Versus Anti-Pseudomonal Cephalosporins and Renal and Neurologic Outcomes in Critically Ill Adults: A Secondary Analysis of the SMART Trial.

Published in:

Journal of Intensive Care Medicine, 2023, v. 38, n. 12, p. 1127, doi. 10.1177/08850666231184177

By:

Qian, Edward T.;
Wang, Li;
Stollings, Joanna L.;
Casey, Jonathan D.;
Rice, Todd W.;
Semler, Matthew W.

Publication type:

Article

Risk of Acute Kidney Injury in Combat-Injured Patients Associated With Concomitant Vancomycin and Extended-Spectrum b-Lactam Antibiotic Use.

Published in:

Journal of Intensive Care Medicine, 2021, v. 36, n. 7, p. 818, doi. 10.1177/0885066620930994

By:

Yabes, Joseph M.;
Stewart, Laveta;
Shaikh, Faraz;
Robben, Paul M.;
Petfield, Joseph L.;
Ganesan, Anuradha;
Campbell, Wesley R.;
Tribble, David R.;
Blyth, Dana M.

Publication type:

Article

The Risk of Acute Kidney Injury in Critically Ill Patients Receiving Concomitant Vancomycin With Piperacillin--Tazobactam or Cefepime.

Published in:

Journal of Intensive Care Medicine, 2020, v. 35, n. 12, p. 1434, doi. 10.1177/0885066619828290

By:

Molina, Kyle C.;
Barletta, Jeffrey F.;
Hall, Scott T.;
Yazdani, Cyrus;
Huang, Vanthida

Publication type:

Article

Piperacillin-tazobactam as alternative to carbapenems for ICU patients.

Published in:

Annals of Intensive Care, 2017, v. 7, n. 1, p. 1, doi. 10.1186/s13613-017-0334-x

By:

Pilmis, Benoit;
Jullien, Vincent;
Tabah, Alexis;
Zahar, Jean-Ralph;
Brun-Buisson, Christian

Publication type:

Article

Flare-Up Diverticulitis in the Terminal Ileum in Short Interval after Conservative Therapy: Report of a Case.

Published in:

2016

By:

Nakatani, Kensuke;
Kato, Takaharu;
Okada, Shinichiro;
Matsumoto, Risa;
Nishida, Kazuhiro;
Komuro, Hiroyasu;
Iida, Maki;
Tsujimoto, Shiro;
Suganuma, Toshiyuki

Publication type:

Case Study

Localized, ovoid urticarial plaques with fine, nonfollicular pustules.

Published in:

2018

By:

Dittmer, M.;
Mutgi, K. A. J.;
Liu, V.;
Swick, B. L.

Publication type:

Case Study

Ecthyma gangrenosum, an important cutaneous infection to recognize in the immunosuppressed patient.

Published in:

Clinical & Experimental Dermatology, 2018, v. 43, n. 1, p. 67, doi. 10.1111/ced.13253

By:

O'Sullivan, G. M.;
Worsnop, F.;
Natkunarajah, J.

Publication type:

Article

Systematic review of piperacillin-induced neutropenia.

Published in:

2007

By:

Scheetz, Marc H.;
McKoy, June M.;
Parada, Jorge P.;
Djulbegovic, Benjamin;
Raisch, Dennis W.;
Yarnold, Paul R.;
Zagory, Jessica;
Trifilio, Steve;
Jakiche, Rita;
Palella, Frank;
Kahn, Adam;
Chandler, Kevin;
Bennett, Charles L.

Publication type:

journal article

Clinical profile of patients treated with cefepime/tazobactam: A new β-lactam/β -lactamase inhibitor combination.

Published in:

Journal of Microbiology & Infectious Diseases, 2012, v. 2, n. 3, p. 79, doi. 10.5799/ahinjs.02.2012.03.0049

By:

Ghafur, Abdul;
Tayade, Ashwini;
Kannaian, Priyadarshini

Publication type:

Article

Sensitivity pattern of Gram negative bacteria to the new β-lactam/ β-lactamase inhibitor combination: Cefepime/tazobactam.

Published in:

Journal of Microbiology & Infectious Diseases, 2012, v. 2, n. 1, p. 5, doi. 10.5799/ahinjs.02.2012.01.0033

By:

Ghafur, Abdul;
Pushparaju, Ramasamy;
Nalini, Sarathy;
Rajkumar, Krishnamurthy;
Sureshkumar, Durairajan

Publication type:

Article

Fatal Postoperative Candida glabrata Septicemia in a Child with Congenital Heart Disease.

Published in:

Journal of Global Infectious Diseases, 2009, v. 1, n. 1, p. 68, doi. 10.4103/0974-777X.52986

By:

Baradkar, Vasant;
Taklikar, Shripad;
Kumar, Simit

Publication type:

Article

Rapid onset severe thrombocytopenia following reexposure to piperacillin-tazobactam: report of two cases and review of the literature.

Published in:

2018

By:

Alzahrani, Musa;
Alrumaih, Ibrahim;
Alhamad, Fahad;
Abdel Warith, Ahmed

Publication type:

Case Study

Vancomycin vs. Vancomycin/Piperacillin-Tazobactam-Associated Acute Kidney Injury in Noncritically Ill Patients at a Tertiary Care Military Treatment Facility.

Published in:

2017

By:

Anderson, Caleb W.;
Cazares, Kathy S.;
Lustik, Michael B.;
Patel, Shivam M.;
Denunzio, Troy M.

Publication type:

journal article

Anchors Away.

Published in:

JGIM: Journal of General Internal Medicine, 2014, v. 29, n. 10, p. 1414, doi. 10.1007/s11606-014-2879-9

By:

Botros, Jacqueline;
Rencic, Joseph;
Centor, Robert;
Henderson, Mark

Publication type:

Article

Outcomes of Bacteremia due to Pseudomonas aeruginosa with Reduced Susceptibility to Piperacillin-Tazobactam: Implications on the Appropriateness of the Resistance Breakpoint.

Published in:

Clinical Infectious Diseases, 2008, v. 46, n. 6, p. 862, doi. 10.1086/528712

By:

Tam, Vincent H.;
Gamez, Eric A.;
Weston, Jaye S.;
Gerard, Laura N.;
LaRocco, Mark T.;
Caeiro, Juan Pablo;
Gentry, Layne O.;
Garey, Kevin W.

Publication type:

Article

Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy.

Published in:

Clinical Infectious Diseases, 2007, v. 44, n. 3, p. 357, doi. 10.1086/510590

By:

Lodise Jr., Thomas P.;
Lomaestro, Ben;
Drusano, George L.

Publication type:

Article

Febrile Neutropenia Associated with Painful Lesions of the Palms and Digits.

Published in:: Clinical Infectious Diseases, 2006, v. 43, n. 6, p. 747, doi. 10.1086/507033
Publication type:: Article

A Randomized, Open-Label, Multicenter Comparative Study of the Efficacy and Safety of Piperacillin-Tazobactam and Cefepime for the Empirical Treatment of Febrile Neutropenic Episodes in Patients with Hematologic Malignancies.

Published in:

Clinical Infectious Diseases, 2006, v. 43, n. 4, p. 447, doi. 10.1086/505393

By:

Bow, E. J.;
Rotstein, C.;
Noskin, G. A.;
Laverdière, M.;
Schwarer, A. P.;
Segal, B. H.;
Seymour, J. F.;
Szer, J.;
Sanche, S.

Publication type:

Article

Lactobacillus Bacteremia, Species Identification, and Antimicrobial Susceptibility of 85 Blood Isolates.

Published in:

Clinical Infectious Diseases, 2006, v. 42, n. 5, p. E35, doi. 10.1086/500214

By:

Salminen, M. K.;
Rautelin, H.;
Tynkkynen, S.;
Poussa, T.;
Saxelin, M.;
Valtonen, V.;
Järvinen, A.

Publication type:

Article

Role of Infectious Diseases Consultants in Management of Antimicrobial Use in Hospitals.

Published in:

Clinical Infectious Diseases, 2004, v. 38, n. 7, p. 934

By:

Sunenshine, Rebecca H.;
Liedtke, Laura A.;
Jernigan, Daniel B.;
Strausbaugh, Larry J.

Publication type:

Article

Treatment with Piperacillin-Tazobactam and False-Positive Aspergillus Galactomannan Antigen Test Results for Patients with Hematological Malignancies.

Published in:

Clinical Infectious Diseases, 2004, v. 38, n. 6, p. 917, doi. 10.1086/383148

By:

Adam, Olivier;
Aupérin, Anne;
Wilquin, Fanny;
Bourhis, Jean-Henri;
Gachot, Bertrand;
Chachaty, Elisabeth

Publication type:

Article

False-Positive Galactomannan Platelia Aspergillus Test Results for Patients Receiving Piperacillin-Tazobactam.

Published in:

Clinical Infectious Diseases, 2004, v. 38, n. 6, p. 913, doi. 10.1086/382224

By:

Viscoli, Claudio;
Cappellano, Paola;
Bucci, Barbara;
Bruzzi, Paolo;
Van Lint, Maria Teresa;
Bacigalupo, Andrea;
Machett, Marco

Publication type:

Article

Incidence of Neutropenia during Treatment of Bone-Related Infections with Piperacillin-Tazobactam.

Published in:

Clinical Infectious Diseases, 2003, v. 37, n. 11, p. 1568, doi. 10.1086/379519

By:

Peralta, F. G.;
Sánchez, M. B.;
Roíz, M. P.;
Pena, M. A.;
Tejero, M. A.;
Arjona, R.

Publication type:

Article

Ertapenem Once Daily Versus Piperacillin-Tazobactam 4 Times per Day for Treatment of Complicated Skin and Skin-Structure Infections in Adults: Results of a Prospective, Randomized, Double-Blind Multicenter Study.

Published in:

Clinical Infectious Diseases, 2002, v. 34, n. 11, p. 1460

By:

Graham, Donald R.;
Lucasti, Christopher;
Malafaia, Osvaldo;
Nichols, Ronald L.;
Holtom, Paul;
Perez, Nora Quintero;
McAdams, Andrea;
Woods, Gail L.;
Ceesay, T. Paulette;
Geeser, Richard

Publication type:

Article

Piperacillin--tazobactam: a β-lactam/β-lactamase inhibitor combination.

Published in:

Expert Review of Anti-infective Therapy, 2007, v. 5, n. 3, p. 365, doi. 10.1586/14787210.5.3.365

By:

Gin, Alfred;
Dilay, Leanne;
Karlowsky, James A.;
Walkty, Andrew;
Rubinstein, Ethan;
Zhanel, George G.

Publication type:

Article

Ceftolozane sulfate with tazobactam sodium.

Published in:: Australian Prescriber, 2016, v. 39, n. 3, p. 106, doi. 10.18773/austprescr.2016.044
Publication type:: Article

Pharmacokinetics of continuous infusion ceftolozane/tazobactam in two patients with extensive total body surface area burns.

Published in:

Pharmacotherapy, 2025, v. 45, n. 6, p. 386, doi. 10.1002/phar.70019

By:

Olivet, Jay D.;
Amerson‐Brown, Megan;
Calix, Juan J.;
Graffice, Emma;
Kilpatrick, Tyson;
Roenfanz, Hanna F.;
Nicolau, David P.;
Kuti, Joseph L.;
Brown, Matthew L.

Publication type:

Article

Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Targets.

Published in:

Pharmacotherapy, 2020, v. 40, n. 10, p. 1061, doi. 10.1002/phar.2462

By:

Tang Girdwood, Sonya;
Arbough, Trent;
Dong, Min;
Mizuno, Tomoyuki;
Tang, Peter;
Vinks, Alexander A.;
Kaplan, Jennifer

Publication type:

Article

Risk factors for piperacillin/tazobactam-resistant Gram-negative infection in hematology/oncology patients with febrile neutropenia.

Published in:

Supportive Care in Cancer, 2015, v. 23, n. 8, p. 2287, doi. 10.1007/s00520-014-2582-8

By:

Marini, Bernard;
Hough, Shannon;
Gregg, Kevin;
Abu-Seir, Haya;
Nagel, Jerod

Publication type:

Article

Susceptibilities of ESBL-Producing Enterobacteriaceae to Ertapenem, Meropenem and Piperacillin-Tazobactam with and without Clavulanic Acid.

Published in:

Chemotherapy (0009-3157), 2007, v. 53, n. 3, p. 185, doi. 10.1159/000100516

By:

Raveh, David;
Yinnon, Amos M.;
Broide, Ellen;
Rudensky, Bernard

Publication type:

Article

Comparative Study of Antibiotic-Containing Polymethylmetacrylate Capsules and Beads.

Published in:

Chemotherapy (0009-3157), 2006, v. 52, n. 1, p. 1, doi. 10.1159/000090233

By:

Börzsei, László;
Mintál, Tibor;
Horváth, Aranka;
Koós, Zoltán;
Kocsis, Béla;
Nyárády, József

Publication type:

Article

In vitro Susceptibility to Meropenem and Other Antimicrobial Agents among Gram-Negative Bacilli Isolated from Hospitalized Patients in Central India.

Published in:

Chemotherapy (0009-3157), 2006, v. 52, n. 1, p. 43, doi. 10.1159/000090243

By:

Chitnis, S.;
Chitnis, V.;
Hemvani, N.;
Chitnis, D.S.

Publication type:

Article

Serum Bactericidal Activity of Piperacillin/Tazobactam against Staphylococcus aureus, Piperacillin-Susceptible and Piperacillin-Resistant Escherichia coli and Pseudomonas aeruginosa.

Published in:

Chemotherapy (0009-3157), 2004, v. 50, n. 1, p. 27, doi. 10.1159/000077281

By:

S.W. Lemmen;
D. Zolldann;
S. Klik;
R. Lütticken;
K. Kümmerer;
H. Häfner

Publication type:

Article

Off-Label Use of Ceftolozane/Tazobactam for the Successful Treatment of Healthcare-Associated Meningitis Caused by Extensively Drug-Resistant Pseudomonas aeruginosa in a Polytraumatized Patient—A Case Report.

Published in:

2022

By:

Dubler, Simon;
Brenner, Thorsten;
Zimmermann, Stefan;
Mokry, Theresa;
Röhr, Anka;
Richter, Daniel C.;
Heininger, Alexandra;
Weigand, Markus A.

Publication type:

Case Study

Stability and Validation of a High-Throughput LC-MS/MS Method for the Quantification of Cefepime, Meropenem, and Piperacillin and Tazobactam in Serum.

Published in:

Journal of Applied Laboratory Medicine, 2021, v. 6, n. 5, p. 1202, doi. 10.1093/jalm/jfab036

By:

Bjergum, Matthew W;
Barreto, Erin F;
Scheetz, Marc H;
Rule, Andrew D;
Jannetto, Paul J

Publication type:

Article

Enterococcus faecalis and Penicillin Susceptibility Testing: The Challenge of Multiple Methods and Agent-to-Agent Predictions.

Published in:

Journal of Applied Laboratory Medicine, 2019, p. 730, doi. 10.1373/jalm.2018.027821

By:

Lines, Tara H.;
Greene, Matthew H.;
Nesbitt, Whitney J.;
Stratton, Charles W.;
Schmitz, Jonathan E.

Publication type:

Article

Fever and reversible laboratory abnormalities associated with prolonged use of piperacillin/tazobactam: A case report.

Published in:

SAGE Open Medical Case Reports, 2024, p. 1, doi. 10.1177/2050313X241285675

By:

Shen, Ling

Publication type:

Article

Incidence and Risk Factors for Acute Kidney Injury in Hospitalized Children Receiving Piperacillin-Tazobactam.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2021, v. 26, n. 6, p. 597, doi. 10.5863/1551-6776-26.6.597

By:

Lu, Hannah;
Thurnherr, Emily;
Meaney, Calvin J.;
Fusco, Nicholas M.

Publication type:

Article

Incidence of Acute Kidney Injury Among Infants in the Neonatal Intensive Care Unit Receiving Vancomycin With Either Piperacillin/Tazobactam or Cefepime.

Published in:

Journal of Pediatric Pharmacology & Therapeutics, 2020, v. 25, n. 6, p. 521, doi. 10.5863/1551-6776-25.6.521

By:

Bartlett, Jenna W.;
Gillon, Jessica;
Hale, Jennifer;
Jimenez-Truque, Natalia;
Banerjee, Ritu

Publication type:

Article

Increase AmpC co-producer ESBL phenotypic detection by using Tazobactam with Cefepime Increase AmpC co-producer ESBL Phenotypic Detection.

Published in:

Egyptian Academic Journal of Biological Sciences, C Physiology & Molecular Biology, 2023, v. 15, n. 1, p. 49, doi. 10.21608/EAJBSC.2023.281335

By:

Ashgar, Sami S.

Publication type:

Article

Tazobactam and piperacillin-induced thrombocytopenia: A case report.

Published in:

Experimental & Therapeutic Medicine, 2016, v. 11, n. 4, p. 1223, doi. 10.3892/etm.2016.3062

By:

HONG CHEN;
ZHEN FAN;
FEI GUO;
YUMIN YANG;
JIE LI;
JIE ZHANG;
YUDAN WANG;
JIANWEI LE;
ZHIYU WANG;
JIANHUA ZHU

Publication type:

Article